Skip to main content
. Author manuscript; available in PMC: 2018 Jul 1.
Published in final edited form as: Mol Pharm. 2017 Oct 25;14(11):3906–3915. doi: 10.1021/acs.molpharmaceut.7b00619

Figure 2.

Figure 2

In vivo fluorescence imaging of PC3-GFP xenograft mice injected with various peptide-Cy5.5 at 10 nmol. Images were taken before and at 0.17, 0.5, 1.5, 3 and 24 hrs after injection (a); in vivo fluorescence intensity of tumors (b) and kidneys (c) under arrows over the period of 24 hrs. Tumor are indicated by full arrows, while kidneys are indicated by dotted arrows; ex vivo fluorescence images of organs at 1.5 hr post injection(d) various peptide-Cy5.5 at 10 nmol. (n = 5).